click to read the latest spotlight stories click to learn more
return to the homepage


2008 Triple Negative Breast Cancer Symposium

Agenda

TOPIC PRESENTER/FACILITATOR TIME
Welcome Allison Axenrod, Hayley Dinerman 8:30 – 8:35
Biology of Triple Negative Breast Cancer
Umbrella of Triple Negative Disease Charles M. Perou 8:35 – 8:50
Update on BRCA1 Pathway Regulation and Targetability in Sporadic Basal-Like Tumors Dan Silver 8:50 – 9:05
Patterns of Metastatic Spread Eric Winer 9:05 – 9:15
Discussion 9:15 – 9:35
Breast Tumor Size, Lymph Node Status And Survival In Triple Negative Breast Cancer: Not So Simple

Update on Prognostic and Therapeutic Implications Of BRCA-Associated Tumors

William D. Foulkes 9:35 – 9:50
Discussion 9:50 – 10:05
Identification and Diagnosis – Should There Be a Unified Approach? Andrea Richardson 10:05 – 10:20
Discussion 10:20 – 10:40
PARP Inhibition as a Therapeutic Strategy - Basic Science and Clinical Trials Andrew Tutt 10:40 – 11:00
Discussion 11:00 – 11:20
Racial Disparities in Triple Negative Disease – Implications for Screening and Treatment Lisa Newman 11:20 – 11:40
Discussion 11:40 – 12:00
LUNCH BREAK 12:00 – 12:40
EGFR Debate
EGFR Is A Relevant Target Lisa Carey 12:40 – 12:50
EGFR Is Not a Relevant Target in Triple Negative Lyndsay Harris 12:50 – 1:00
Discussion 1:00 – 1:20
Platinum Agents Debate
Platinum Agents Are Relevant for Triple Negative Steve Isakoff 1:20 – 1:30
Platinum Agents Are Not Significant for Triple Negative Cliff Hudis 1:30 – 1:40
Discussion 1:40– 2:00
Facilitated Discussion – Appropriate Targets and Most Promising Avenues George Sledge/Eric Winer 2:00 – 3:00
< back

TNBC Foundation and Triple Negative Breast Cancer Foundation are registered trademarks of Triple Negative Breast Cancer Foundation, Inc.
Homepage | ฉ 2011 TNBC Foundation, Inc. | Disclaimer